Monopar Therapeutics Inc (MNPR)

Apr 10, 2025

Monopar Therapeutics Inc. acquired worldwide license to ALXN-18 from Alexion Pharmaceuticals, Inc. for approximately $110 million. - MarketScreener

Apr 10, 2025

Apr 06, 2025

(MNPR) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025

Apr 04, 2025

Major Shareholder Sells Big Chunk of Monopar Therapeutics Stock! - TipRanks

Apr 04, 2025

Apr 04, 2025

Monopar Therapeutics CEO Robinson sells $1.17 million in stock By Investing.com - Investing.com Canada

Apr 04, 2025

Apr 04, 2025

Jones Trading Reiterates “Hold” Rating for Monopar Therapeutics (NASDAQ:MNPR) - Defense World

Apr 04, 2025

Apr 04, 2025

HC Wainwright Issues Negative Forecast for MNPR Earnings - Defense World

Apr 04, 2025

Apr 03, 2025

What is HC Wainwright’s Forecast for MNPR FY2029 Earnings? - Defense World

Apr 03, 2025

Apr 02, 2025

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch - TipRanks

Apr 02, 2025

Apr 02, 2025

We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth - Yahoo Finance

Apr 02, 2025

Apr 02, 2025

Monopar Therapeutics (NASDAQ:MNPR) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 02, 2025

Apr 01, 2025

Top 5 Small-cap Biotech Stocks of 2025 - Nasdaq

Apr 01, 2025

Apr 01, 2025

Monopar Therapeutics Stock Hits 52-Week High at $38.91 - MSN

Apr 01, 2025

Apr 01, 2025

Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Projections Justify Buy Rating - TipRanks

Apr 01, 2025

Apr 01, 2025

Buy Rating for Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Outlook - TipRanks

Apr 01, 2025

Mar 31, 2025

Monopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last year - TipRanks

Mar 31, 2025

Mar 31, 2025

Monopar Therapeutics sees cash runway through December 31, 2026 - TipRanks

Mar 31, 2025

Mar 31, 2025

Monopar Therapeutics Inc. (MNPR) reports earnings - Quartz

Mar 31, 2025

Mar 31, 2025

Monopar Therapeutics SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

Monopar Secures 2-Year Runway with $60M War Chest, Advances Wilson Disease Drug - Stock Titan

Mar 31, 2025

Mar 28, 2025

MNPR Stock Price and Chart — NASDAQ:MNPR - TradingView

Mar 28, 2025

Mar 21, 2025

Here's Why Momentum in Monopar Therapeutics (MNPR) Should Keep going - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

Piper Sandler Reaffirms “Overweight” Rating for Monopar Therapeutics (NASDAQ:MNPR) - Defense World

Mar 21, 2025

Mar 20, 2025

Monopar Therapeutics (MNPR) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 19, 2025

Monopar a new overweight at Piper Sandler on rare disease asset - Seeking Alpha

Mar 19, 2025

Mar 19, 2025

Piper Sandler sets Monopar stock at $76 with Overweight rating - Investing.com

Mar 19, 2025

Mar 19, 2025

Buy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential - TipRanks

Mar 19, 2025

Mar 19, 2025

Piper Sandler sets Monopar stock at $76 with Overweight rating By Investing.com - Investing.com UK

Mar 19, 2025

Mar 16, 2025

(MNPR) Trading Report - news.stocktradersdaily.com

Mar 16, 2025

Mar 08, 2025

Monopar Therapeutics Inc.'s (NASDAQ:MNPR) 19% loss last week hit both individual investors who own 33% as well as institutions - Simply Wall St

Mar 08, 2025

Mar 04, 2025

Monopar Therapeutics: Strong Data, But There Are Risks (NASDAQ:MNPR) - Seeking Alpha

Mar 04, 2025

Mar 03, 2025

Monopar Therapeutics appoints new CFO - Investing.com

Mar 03, 2025

Mar 03, 2025

Monopar Therapeutics Appoints Quan Vu as New CFO - TipRanks

Mar 03, 2025

Mar 03, 2025

Monopar Therapeutics Inc Says On Feb 28, CFO Karthik Radhakrishnan'S Employment Terminated - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Monopar Therapeutics appoints new CFO By Investing.com - Investing.com Australia

Mar 03, 2025

Feb 24, 2025

Monopar Therapeutics appoints new board member - Investing.com

Feb 24, 2025

Feb 24, 2025

Monopar Therapeutics appoints new board member By Investing.com - Investing.com UK

Feb 24, 2025

Feb 24, 2025

Monopar Therapeutics Appoints Lavina Talukdar to Board - TipRanks

Feb 24, 2025

Feb 23, 2025

Trend Tracker for (MNPR) - Stock Traders Daily

Feb 23, 2025

Feb 19, 2025

Copper wired: Monopar to electrify Wilson disease? - BioWorld Online

Feb 19, 2025

Feb 13, 2025

Q1 EPS Estimate for Monopar Therapeutics Raised by Analyst - MarketBeat

Feb 13, 2025

Feb 12, 2025

Learn to Evaluate (MNPR) using the Charts - Stock Traders Daily

Feb 12, 2025

Feb 11, 2025

Brookline Capital Management Forecasts MNPR Q1 Earnings - Defense World

Feb 11, 2025

Feb 06, 2025

Monopar's Incredible Journey From $5 To $50 In Less Than 5 Months - RTTNews

Feb 06, 2025

Feb 04, 2025

Why Monopar Therapeutics Inc (MNPR) Is Skyrocketing So Far In 2025 - MSN

Feb 04, 2025

Feb 03, 2025

Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025

Jan 27, 2025

What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? - MSN

Jan 27, 2025

Jan 26, 2025

What is HC Wainwright’s Forecast for MNPR FY2026 Earnings? - Defense World

Jan 26, 2025

Jan 24, 2025

Analysts Set Expectations for MNPR FY2029 Earnings - MarketBeat

Jan 24, 2025

Jan 24, 2025

What is HC Wainwright's Forecast for MNPR FY2026 Earnings? - MarketBeat

Jan 24, 2025